Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease

Ähnliche Einträge

• Randomized, double-blind, parallel-group,48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in Alzheimer’s disease
  Veröffentlicht: (2012)
• Randomized, double-Blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm2) in Alzheimer’s disease
  von: Cummings, Jeffrey L., et al.
  Veröffentlicht: (2012)
• Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease
  Veröffentlicht: (2013)
• Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch
  von: Molinuevo, José L., et al.
  Veröffentlicht: (2015)
• Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate
  von: Mamoulakis, Charalampos, et al.
  Veröffentlicht: (2012)